r/Inovio

Institutions and Hedge funds own = 26.79% of shares- they are playing for our side from the Big Boys' team. Note our 50 day moving average was $1.03 as of yesterday. Evidently rising as shares have traded ~$1.15 plus or minus this week.

The attempt to push inovio below $1 failed and the team of shorts are looking at huge losses on the 16 million short shares they borrowed and have to return. Inovio will never be delisted from the Nasdaq stock exchange. The squeeze will continue through next week for the monthly stock expiration date will require shorts to cover or else continue to pay for their underwater positions. Profitez mes amis, the money will flow in through Friday close of the market. Note we’re on the verge of the issue price of the company’s $18 million share sale at $1.10, which is not yet available for sale yet, but check the date shares become available for your own information. This may present a temporary ceiling price for shares; but the $18 million dollars will extend the company runway for launching Ino-3107, following the 10/30/26 expected PDUFA date- after which will bring product sales revenues. Btw consider the influence that ApolloBio sales of 3100 will have on the share price- 11% is inovio’s % of the profit and analysts value the company around $4. Don’t tell the short schmucks about that, please- we need them to keep selling us cheap shares (!)

Grok finds 3 forecasts for Inovio price in 2027 from $2.50-$4 and is my first time using Grok.

Just trying to understand.

I am a senior technical partner for a very big company, handling 20 to 30 reqs on average, direct line to stakeholders. VP level and high level IC hires.

Been here for 3 years, previous to this I was at a 3rd party agency where I handled startups all the way to enterprise accounts, average req load was around 20. All of this on the technical side

I’ve been recruiting for 13 years and only have these two companies I have recruited for.

Have done everything from AI to aerospace, software engineering, product, infra, cloud, data and security.

Despite this I can’t get an interview anywhere. Rejected within hours to positions that I would seemingly be a very good fit for. Just to see these same positions reposted week after week online.

Anyone dealing with this? I’m open to tweaks and suggestions and I really would love to explore something new.

From (revised previous) post about the value of the Ino-Apollobio 3100 profitsharing agreement with ApolloBio from Stocktwits.com:

"...If I recall, the profit sharing % is in the low teens, probably a sliding rate based on volume, between 11%-14%; I believe ApolloBio is aiming for a worldwide license; so the market per WHO estimate is 167 million cases...will take time to deliver all that product but a long term agreement worth, assume $900 per treatment, 50% profit per shot, $450 *165 million treatments= $75 million; as to which (?) 11% is =$8.2 million cumulatively, per the agreement. In effect a deferred revenue source of $8.2MM per share. Wall Street values the shares at 8.76 times Book Value, hence $72 MM in future Sales assumed, $72MM cash revenue less expenses $24 MM/yr. = net earnings $48 MM so Book Value $48MM; X 8.76,= $420MM div. by 100# MM shares= $4.20 a share.

All for under a buck a better deal than a pack of beer nuts.

Well that was short and sweet.

Nothing to analyze. We are good to go.

Launch funding already baked in. Eight months of runway.

Funeral date remains October 30 for shorts.

This is happening.

All of it.

imho

xx